SCOPE: Red meat is considered a risk factor for colorectal cancer (CRC). Heme is considered to promote colonic hyperproliferation and cell damage. Resistant starch (RS) is a food that ferments in the colon with studies demonstrating protective effects against CRC. By utilizing the western diet model of spontaneous CRC, we determined if feeding heme (as hemin chloride) equivalent to a high red meat diet would increase colonic DNA adducts and CRC and whether RS could abrogate such effects. METHODS AND RESULTS: Four groups of mice: control, heme, RS and heme + RS were fed diets for 1 or 18 months. Colons were analyzed for apoptosis, proliferation, DNA adducts "8-hydroxy-2-deoxyguanosine" and "O(6) -methyl-2-deoxyguanosine" (O(6) MeG), and neoplasms. In the short term, heme increased cell proliferation (p < 0.05). Changes from 1 to 18 months showed increased cell proliferation (p < 0.01) and 8-hydroxy-2-deoxyguanosine adducts (p < 0.05) in all groups, but only heme-fed mice showed reduced apoptosis (p < 0.01) and increased O(6) MeG adducts (p < 0.01). The incidence of colon neoplasms was not different between any interventions. CONCLUSION: We identified heme to increase proliferation in the short term, inhibit apoptosis over the long term, and increase O(6) MeG adducts in the colon over time although these changes did not affect colonic neoplasms within this mouse model.
SCOPE: Red meat is considered a risk factor for colorectal cancer (CRC). Heme is considered to promote colonic hyperproliferation and cell damage. Resistant starch (RS) is a food that ferments in the colon with studies demonstrating protective effects against CRC. By utilizing the western diet model of spontaneous CRC, we determined if feeding heme (as hemin chloride) equivalent to a high red meat diet would increase colonic DNA adducts and CRC and whether RS could abrogate such effects. METHODS AND RESULTS: Four groups of mice: control, heme, RS and heme + RS were fed diets for 1 or 18 months. Colons were analyzed for apoptosis, proliferation, DNA adducts "8-hydroxy-2-deoxyguanosine" and "O(6) -methyl-2-deoxyguanosine" (O(6) MeG), and neoplasms. In the short term, heme increased cell proliferation (p < 0.05). Changes from 1 to 18 months showed increased cell proliferation (p < 0.01) and 8-hydroxy-2-deoxyguanosine adducts (p < 0.05) in all groups, but only heme-fed mice showed reduced apoptosis (p < 0.01) and increased O(6) MeG adducts (p < 0.01). The incidence of colon neoplasms was not different between any interventions. CONCLUSION: We identified heme to increase proliferation in the short term, inhibit apoptosis over the long term, and increase O(6) MeG adducts in the colon over time although these changes did not affect colonic neoplasms within this mouse model.
Authors: Lieselot Y Hemeryck; Caroline Rombouts; Thomas Van Hecke; Lieven Van Meulebroek; Julie Vanden Bussche; Stefaan De Smet; Lynn Vanhaecke Journal: Toxicol Res (Camb) Date: 2016-06-22 Impact factor: 3.524
Authors: Richard K Le Leu; Jean M Winter; Claus T Christophersen; Graeme P Young; Karen J Humphreys; Ying Hu; Silvia W Gratz; Rosalind B Miller; David L Topping; Anthony R Bird; Michael A Conlon Journal: Br J Nutr Date: 2015-06-17 Impact factor: 3.718
Authors: Christina Steppeler; Marianne Sødring; Bjørg Egelandsdal; Bente Kirkhus; Marije Oostindjer; Ole Alvseike; Lars Erik Gangsei; Ellen-Margrethe Hovland; Fabrice Pierre; Jan Erik Paulsen Journal: PLoS One Date: 2017-04-20 Impact factor: 3.240
Authors: Fiona C Malcomson; Naomi D Willis; Iain McCallum; Long Xie; Arthur C Ouwehand; Julian D Stowell; Seamus Kelly; D Michael Bradburn; Nigel J Belshaw; Ian T Johnson; John C Mathers Journal: Br J Nutr Date: 2020-04-13 Impact factor: 3.718